·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊ½ºÅ¸Å¬·´TVÆÊµµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ »õ³»±â¾à»ç 1879¸í ¹èÃâ...°æ»ó±¹¸³´ë ¼ÛÇöÁØ ¾¾ ¼ö¼® ±â»çÀÔ·Â : 24.02.01 17:03:59 0 °¡ ÇÃÄ£Ãß°¡ ¾à»ç±¹½Ã ÀÀ½Ã 2071¸í...ÇÕ°Ý·ü 90.7% Àü³â ´ëºñ ÇÕ°Ý·ü 3% Ç϶ô [µ¥Àϸ®ÆÊ=Á¤ÈïÁØ ±âÀÚ] ¾à´ë»ý 1879¸íÀÌ ¾à»ç ±¹½Ã¿¡ ÇÕ°ÝÇß´Ù. À̹ø ¾à»ç ±¹½Ã¿¡´Â 2071¸íÀÇ ¾à´ë»ýÀÌ ÀÀ½ÃÇØ ÇÕ°Ý·ü 90.7%¸¦ ±â·ÏÇß´Ù. À۳⿣ 2014¸íÀÌ ÀÀ½ÃÇØ ÇÕ°Ý·ü 93.7%·Î 1887¸íÀÇ »õ³»±â ¾à»ç°¡ ¹èÃâµÈ ¹Ù ÀÖ´Ù. ¿ÃÇØ ÇÕ°Ý·üÀÌ ¾à 3% ³·¾ÆÁ³´Ù. ¾à»ç ±¹½Ã ¼ö¼®ÇÕ°ÝÀº °æ»ó±¹¸³´ë ¼ÛÇöÁØ ¾¾°¡ Â÷ÁöÇß´Ù. 350Á¡ ¸¸Á¡¿¡ 322Á¡(92Á¡/100Á¡ ȯ»ê ±âÁØ)À» ¹Þ¾Ò´Ù. 1ÀÏ Çѱ¹º¸°ÇÀÇ·áÀα¹°¡½ÃÇè¿ø(¿øÀå ¹èÇöÁÖ, ÀÌÇÏ ±¹½Ã¿ø)Àº Áö³´Þ ¼¿ï µî Àü±¹ 6°³ Áö¿ª, 7°³ ½ÃÇèÀå¿¡¼ ½ÃÇèµÈ Á¦75ȸ ¾à»ç ±¹°¡½ÃÇè ÇÕ°ÝÀÚ¸¦ ¹ßÇ¥Çß´Ù. ¾à»ç ±¹½Ã ÇÕ°Ý¿©ºÎ´Â ±¹½Ã¿ø ȨÆäÀÌÁö(www.kuksiwon.or.kr)¸¦ ÅëÇØ È®ÀÎÀÌ °¡´ÉÇÏ¸ç ±¹½Ã¿øÀº ¿ø¼Á¢¼ö ½Ã ¿¬¶ôó¸¦ ±âÀçÇÑ ÀÀ½ÃÀÚ¿¡°Ô ¹®ÀÚ¸Þ½ÃÁö¸¦ ÅëÇØ¼µµ Á÷Á¢ ÇÕ°Ý¿©ºÎ¸¦ ¾Ë·ÁÁÙ ¿¹Á¤ÀÌ´Ù. X AD ²ÜÁ¶ÇÕ Ã£¾Æº¸±â! À̺¥Æ®Âü¿© ¡æ Á¤ÈïÁØ ±âÀÚ(jhj@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °ü·Ã±â»ç · ½ÅÂü¾à»ç 1900¸í ½ÃÀåÀ¸·Î...º´¿ø¡¤¾à±¹¡¤¾÷ü ±¸... · ¾à»ç±¹½Ã '¾àÄ¡' ¾î·Á¿ü´Ù..."À۳⺸´Ù ü°¨ ³ÀÌ... · À̹ø ¾à»ç±¹½Ã 2071¸í ÀÀ½Ã...À۳⺸´Ù 56¸í ´Ã¾ú´Ù °æ·ÂÁ÷ MRä¿ë (¼öµµ±Ç) ¹Ù·Î°¡±â R&D¼¾ÅÍ ¿¬±¸¿ø ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â 2025³â »ó¹Ý±â ¼ö½Ãä¿ë(ÇмúÀÇÇнÇ, BDÆÀ ¾à»ç) ¹Ù·Î°¡±â RA, PMS, MSL ,PM, MR, MM µî °¢ ºÎ¹® ¸ðÁý ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë ¹Ù·Î°¡±â [Çѵ¶] Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®, MA, Ãѹ« ÆÀÀå, Á¦Á¶°ü¸® ¾à»ç, ÀÌÈÇнÃÇè(QC), ±â¼úÆÀ ±³Á¤´ã´ç, Àü¹®ÀǾàǰ ¸¶ÄÉÆÃ, ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â Sr. RA Specialist & RA Specialist (2 Year Contract) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : »õ³»±â¾à»ç 1879¸í ¹èÃâ...°æ»ó±¹¸³´ë ¼ÛÇöÁØ ¾¾ ¼ö¼® URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ »õ³»±â¾à»ç 1879¸í ¹èÃâ...°æ»ó±¹¸³´ë ¼ÛÇöÁØ ¾¾ ¼ö¼® ±â»çÀÔ·Â : 24.02.01 17:03:59 0 °¡ ÇÃÄ£Ãß°¡ ¾à»ç±¹½Ã ÀÀ½Ã 2071¸í...ÇÕ°Ý·ü 90.7% Àü³â ´ëºñ ÇÕ°Ý·ü 3% Ç϶ô [µ¥Àϸ®ÆÊ=Á¤ÈïÁØ ±âÀÚ] ¾à´ë»ý 1879¸íÀÌ ¾à»ç ±¹½Ã¿¡ ÇÕ°ÝÇß´Ù. À̹ø ¾à»ç ±¹½Ã¿¡´Â 2071¸íÀÇ ¾à´ë»ýÀÌ ÀÀ½ÃÇØ ÇÕ°Ý·ü 90.7%¸¦ ±â·ÏÇß´Ù. À۳⿣ 2014¸íÀÌ ÀÀ½ÃÇØ ÇÕ°Ý·ü 93.7%·Î 1887¸íÀÇ »õ³»±â ¾à»ç°¡ ¹èÃâµÈ ¹Ù ÀÖ´Ù. ¿ÃÇØ ÇÕ°Ý·üÀÌ ¾à 3% ³·¾ÆÁ³´Ù. ¾à»ç ±¹½Ã ¼ö¼®ÇÕ°ÝÀº °æ»ó±¹¸³´ë ¼ÛÇöÁØ ¾¾°¡ Â÷ÁöÇß´Ù. 350Á¡ ¸¸Á¡¿¡ 322Á¡(92Á¡/100Á¡ ȯ»ê ±âÁØ)À» ¹Þ¾Ò´Ù. 1ÀÏ Çѱ¹º¸°ÇÀÇ·áÀα¹°¡½ÃÇè¿ø(¿øÀå ¹èÇöÁÖ, ÀÌÇÏ ±¹½Ã¿ø)Àº Áö³´Þ ¼¿ï µî Àü±¹ 6°³ Áö¿ª, 7°³ ½ÃÇèÀå¿¡¼ ½ÃÇèµÈ Á¦75ȸ ¾à»ç ±¹°¡½ÃÇè ÇÕ°ÝÀÚ¸¦ ¹ßÇ¥Çß´Ù. ¾à»ç ±¹½Ã ÇÕ°Ý¿©ºÎ´Â ±¹½Ã¿ø ȨÆäÀÌÁö(www.kuksiwon.or.kr)¸¦ ÅëÇØ È®ÀÎÀÌ °¡´ÉÇÏ¸ç ±¹½Ã¿øÀº ¿ø¼Á¢¼ö ½Ã ¿¬¶ôó¸¦ ±âÀçÇÑ ÀÀ½ÃÀÚ¿¡°Ô ¹®ÀÚ¸Þ½ÃÁö¸¦ ÅëÇØ¼µµ Á÷Á¢ ÇÕ°Ý¿©ºÎ¸¦ ¾Ë·ÁÁÙ ¿¹Á¤ÀÌ´Ù. X AD ²ÜÁ¶ÇÕ Ã£¾Æº¸±â! À̺¥Æ®Âü¿© ¡æ Á¤ÈïÁØ ±âÀÚ(jhj@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °ü·Ã±â»ç · ½ÅÂü¾à»ç 1900¸í ½ÃÀåÀ¸·Î...º´¿ø¡¤¾à±¹¡¤¾÷ü ±¸... · ¾à»ç±¹½Ã '¾àÄ¡' ¾î·Á¿ü´Ù..."À۳⺸´Ù ü°¨ ³ÀÌ... · À̹ø ¾à»ç±¹½Ã 2071¸í ÀÀ½Ã...À۳⺸´Ù 56¸í ´Ã¾ú´Ù °æ·ÂÁ÷ MRä¿ë (¼öµµ±Ç) ¹Ù·Î°¡±â R&D¼¾ÅÍ ¿¬±¸¿ø ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â 2025³â »ó¹Ý±â ¼ö½Ãä¿ë(ÇмúÀÇÇнÇ, BDÆÀ ¾à»ç) ¹Ù·Î°¡±â RA, PMS, MSL ,PM, MR, MM µî °¢ ºÎ¹® ¸ðÁý ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë ¹Ù·Î°¡±â [Çѵ¶] Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®, MA, Ãѹ« ÆÀÀå, Á¦Á¶°ü¸® ¾à»ç, ÀÌÈÇнÃÇè(QC), ±â¼úÆÀ ±³Á¤´ã´ç, Àü¹®ÀǾàǰ ¸¶ÄÉÆÃ, ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â Sr. RA Specialist & RA Specialist (2 Year Contract) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : »õ³»±â¾à»ç 1879¸í ¹èÃâ...°æ»ó±¹¸³´ë ¼ÛÇöÁØ ¾¾ ¼ö¼® URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ »õ³»±â¾à»ç 1879¸í ¹èÃâ...°æ»ó±¹¸³´ë ¼ÛÇöÁØ ¾¾ ¼ö¼® ±â»çÀÔ·Â : 24.02.01 17:03:59 0 °¡ ÇÃÄ£Ãß°¡ ¾à»ç±¹½Ã ÀÀ½Ã 2071¸í...ÇÕ°Ý·ü 90.7% Àü³â ´ëºñ ÇÕ°Ý·ü 3% Ç϶ô [µ¥Àϸ®ÆÊ=Á¤ÈïÁØ ±âÀÚ] ¾à´ë»ý 1879¸íÀÌ ¾à»ç ±¹½Ã¿¡ ÇÕ°ÝÇß´Ù. À̹ø ¾à»ç ±¹½Ã¿¡´Â 2071¸íÀÇ ¾à´ë»ýÀÌ ÀÀ½ÃÇØ ÇÕ°Ý·ü 90.7%¸¦ ±â·ÏÇß´Ù. À۳⿣ 2014¸íÀÌ ÀÀ½ÃÇØ ÇÕ°Ý·ü 93.7%·Î 1887¸íÀÇ »õ³»±â ¾à»ç°¡ ¹èÃâµÈ ¹Ù ÀÖ´Ù. ¿ÃÇØ ÇÕ°Ý·üÀÌ ¾à 3% ³·¾ÆÁ³´Ù. ¾à»ç ±¹½Ã ¼ö¼®ÇÕ°ÝÀº °æ»ó±¹¸³´ë ¼ÛÇöÁØ ¾¾°¡ Â÷ÁöÇß´Ù. 350Á¡ ¸¸Á¡¿¡ 322Á¡(92Á¡/100Á¡ ȯ»ê ±âÁØ)À» ¹Þ¾Ò´Ù. 1ÀÏ Çѱ¹º¸°ÇÀÇ·áÀα¹°¡½ÃÇè¿ø(¿øÀå ¹èÇöÁÖ, ÀÌÇÏ ±¹½Ã¿ø)Àº Áö³´Þ ¼¿ï µî Àü±¹ 6°³ Áö¿ª, 7°³ ½ÃÇèÀå¿¡¼ ½ÃÇèµÈ Á¦75ȸ ¾à»ç ±¹°¡½ÃÇè ÇÕ°ÝÀÚ¸¦ ¹ßÇ¥Çß´Ù. ¾à»ç ±¹½Ã ÇÕ°Ý¿©ºÎ´Â ±¹½Ã¿ø ȨÆäÀÌÁö(www.kuksiwon.or.kr)¸¦ ÅëÇØ È®ÀÎÀÌ °¡´ÉÇÏ¸ç ±¹½Ã¿øÀº ¿ø¼Á¢¼ö ½Ã ¿¬¶ôó¸¦ ±âÀçÇÑ ÀÀ½ÃÀÚ¿¡°Ô ¹®ÀÚ¸Þ½ÃÁö¸¦ ÅëÇØ¼µµ Á÷Á¢ ÇÕ°Ý¿©ºÎ¸¦ ¾Ë·ÁÁÙ ¿¹Á¤ÀÌ´Ù. X AD ²ÜÁ¶ÇÕ Ã£¾Æº¸±â! À̺¥Æ®Âü¿© ¡æ Á¤ÈïÁØ ±âÀÚ(jhj@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
°ü·Ã±â»ç · ½ÅÂü¾à»ç 1900¸í ½ÃÀåÀ¸·Î...º´¿ø¡¤¾à±¹¡¤¾÷ü ±¸... · ¾à»ç±¹½Ã '¾àÄ¡' ¾î·Á¿ü´Ù..."À۳⺸´Ù ü°¨ ³ÀÌ... · À̹ø ¾à»ç±¹½Ã 2071¸í ÀÀ½Ã...À۳⺸´Ù 56¸í ´Ã¾ú´Ù
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : »õ³»±â¾à»ç 1879¸í ¹èÃâ...°æ»ó±¹¸³´ë ¼ÛÇöÁØ ¾¾ ¼ö¼® URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö